AR013175A1 - Uso de bacteria de acido lactico para preparar una composicion oral para mamiferos util para facilitar la absorcion - Google Patents

Uso de bacteria de acido lactico para preparar una composicion oral para mamiferos util para facilitar la absorcion

Info

Publication number
AR013175A1
AR013175A1 ARP980103248A ARP980103248A AR013175A1 AR 013175 A1 AR013175 A1 AR 013175A1 AR P980103248 A ARP980103248 A AR P980103248A AR P980103248 A ARP980103248 A AR P980103248A AR 013175 A1 AR013175 A1 AR 013175A1
Authority
AR
Argentina
Prior art keywords
lactic acid
acid bacteria
prepare
oral composition
facilitate absorption
Prior art date
Application number
ARP980103248A
Other languages
English (en)
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227023&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR013175(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of AR013175A1 publication Critical patent/AR013175A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C13/00—Cream; Cream preparations; Making thereof
    • A23C13/12—Cream preparations
    • A23C13/16—Cream preparations containing, or treated with, microorganisms, enzymes, or antibiotics; Sour cream
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/151—Johnsonii
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Uso de bacterias de ácido láctico para la preparacion de una composicion prevista para ser administrada oralmente a un mamífero demanera de facilitar la absorcion, por las células intestinales, de los minerales presentes enun a dieta diaria. Las composiciones son particularmenteadecuadas para el tratamiento o la profilaxis de personas que tienen deficiencias de minerales, o para compensar las deficiencias fisiologicasdebidas a una dieta baja en minerales, opar a satisfacer requerimiento fisiologicos importantes de minerales en ninos, mujeres embarazadas, mujeresque están amamantando y personas mayores.
ARP980103248A 1997-07-05 1998-07-03 Uso de bacteria de acido lactico para preparar una composicion oral para mamiferos util para facilitar la absorcion AR013175A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97111380 1997-07-05

Publications (1)

Publication Number Publication Date
AR013175A1 true AR013175A1 (es) 2000-12-13

Family

ID=8227023

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980103248A AR013175A1 (es) 1997-07-05 1998-07-03 Uso de bacteria de acido lactico para preparar una composicion oral para mamiferos util para facilitar la absorcion

Country Status (26)

Country Link
US (1) US20020127211A1 (es)
EP (1) EP1003532B2 (es)
JP (1) JP2002507997A (es)
KR (1) KR20010015563A (es)
CN (1) CN1269724A (es)
AR (1) AR013175A1 (es)
AT (1) ATE208205T1 (es)
AU (1) AU743914B2 (es)
BR (1) BR9810547B1 (es)
CA (1) CA2294099C (es)
CZ (1) CZ300387B6 (es)
DE (1) DE69802413T3 (es)
DK (1) DK1003532T4 (es)
ES (1) ES2168785T5 (es)
HK (1) HK1029737A1 (es)
HU (1) HUP0003995A3 (es)
IL (1) IL133412A (es)
MY (1) MY122501A (es)
NO (1) NO322188B1 (es)
NZ (1) NZ501933A (es)
PL (1) PL337967A1 (es)
PT (1) PT1003532E (es)
RU (1) RU2214258C2 (es)
TR (1) TR200000021T2 (es)
WO (1) WO1999002170A1 (es)
ZA (1) ZA985893B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197356B1 (en) * 1993-08-03 2001-03-06 Immunopath Profile, Inc. Process for preparing hypoallergenic foods
RU2214258C2 (ru) * 1997-07-05 2003-10-20 Сосьете Де Продюи Нестле С.А. Всасывание минеральных веществ кишечными клетками
DE10008279A1 (de) * 2000-02-23 2001-08-30 Meggle Gmbh Milchzucker enthaltende Zusammensetzung
JP3363438B2 (ja) 2000-05-02 2003-01-08 ビオフェルミン製薬株式会社 噴霧乾燥による菌体乾燥物
GB0027761D0 (en) * 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
KR100419132B1 (ko) * 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
DE10213280A1 (de) * 2002-03-25 2003-10-23 Mars Inc Proteinhaltiges Nahrungsmittelerzeugnis und Verfahren zu seiner Herstellung
EP1477173B1 (en) * 2003-05-16 2007-12-19 Kao Corporation Use of monosaccharide posphates for improving the intestinal function
JP4485169B2 (ja) * 2003-05-16 2010-06-16 花王株式会社 腸管ミネラル吸収能改善剤
JP4782385B2 (ja) * 2003-05-29 2011-09-28 昭和産業株式会社 免疫賦活剤
PT1638416E (pt) * 2003-06-23 2013-07-08 Nestec Sa Utilização de uma fórmula nutricional para função de barreira intestinal óptima
JP4553604B2 (ja) * 2003-06-30 2010-09-29 明治製菓株式会社 一般食品、保健機能食品または健康補助食品の機能増強組成物及びその方法
US6936598B2 (en) * 2003-11-21 2005-08-30 Hill's Pet Nutrition, Inc. Composition and method
US7754677B2 (en) * 2003-12-05 2010-07-13 Hill's Pet Nutrition, Inc. Composition and method for reducing diarrhea in a mammal
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
WO2006012739A1 (en) * 2004-08-02 2006-02-09 UNIVERSITé LAVAL Nutritional ingredient containing bioavailable mineral nutrients
EP1855550B1 (en) * 2005-02-28 2011-10-05 N.V. Nutricia Nutritional composition with probiotics
EP1885383B1 (en) 2005-05-31 2016-09-21 IAMS Europe B.V. Feline probiotic bifidobacteria
AR052472A1 (es) 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8287931B2 (en) 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
SE529199C2 (sv) * 2005-07-05 2007-05-29 Probi Ab Förstärkt absorption
DK1992351T3 (en) * 2007-05-18 2016-06-06 Nestec Sa Lactobacillus johnsonii for the prevention of post-surgical infection
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
WO2010061877A1 (ja) * 2008-11-28 2010-06-03 明治乳業株式会社 ミネラル吸収改善剤およびミネラル吸収改善方法
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US20110070334A1 (en) 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
US10039296B2 (en) 2011-06-20 2018-08-07 H.J. Heinz Company Brands Llc Probiotic compositions and methods
CN104363769B (zh) * 2012-02-28 2016-08-24 康奈尔大学 益生菌组合物和方法
US10245290B2 (en) * 2013-04-03 2019-04-02 Probi Ab Probiotic strains for use in treatment or prevention of osteoporosis
CN108030096A (zh) * 2017-12-18 2018-05-15 浙江民生健康科技有限公司 一种钙铁锌与益生菌组合物及其应用
CN115884688A (zh) * 2020-05-25 2023-03-31 热尔韦·达诺尼公司 用于预防或治疗矿物质缺乏的乳酸乳球菌

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2536996B1 (fr) * 1982-12-01 1985-09-27 Grimberg Georges Association permettant d'ameliorer l'absorption de divers cations par l'organisme
JPH0678367B2 (ja) * 1990-05-15 1994-10-05 呉羽化学工業株式会社 食物繊維、その製造法及びその食物繊維を含有する生理活性剤
DE69219768T2 (de) * 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
JP3618774B2 (ja) * 1993-08-10 2005-02-09 雪印乳業株式会社 鉄欠乏性貧血治療用組成物
JPH10158178A (ja) * 1996-11-29 1998-06-16 Yakult Honsha Co Ltd ミネラル吸収促進剤およびミネラル強化剤
RU2214258C2 (ru) * 1997-07-05 2003-10-20 Сосьете Де Продюи Нестле С.А. Всасывание минеральных веществ кишечными клетками

Also Published As

Publication number Publication date
NO996214L (no) 1999-12-15
IL133412A0 (en) 2001-04-30
HUP0003995A3 (en) 2002-01-28
DE69802413T3 (de) 2009-07-16
PT1003532E (pt) 2002-04-29
BR9810547B1 (pt) 2013-06-04
AU743914B2 (en) 2002-02-07
HK1029737A1 (en) 2001-04-12
CA2294099C (en) 2008-04-01
NO322188B1 (no) 2006-08-28
JP2002507997A (ja) 2002-03-12
NO996214D0 (no) 1999-12-15
KR20010015563A (ko) 2001-02-26
DE69802413D1 (de) 2001-12-13
CN1269724A (zh) 2000-10-11
HUP0003995A2 (en) 2001-03-28
DK1003532T3 (da) 2002-01-07
PL337967A1 (en) 2000-09-11
WO1999002170A1 (en) 1999-01-21
CA2294099A1 (en) 1999-01-21
ES2168785T3 (es) 2002-06-16
NZ501933A (en) 2001-08-31
RU2214258C2 (ru) 2003-10-20
ZA985893B (en) 2000-01-10
EP1003532B1 (en) 2001-11-07
TR200000021T2 (tr) 2001-01-22
DK1003532T4 (da) 2009-03-02
ES2168785T5 (es) 2009-04-16
CZ200023A3 (cs) 2000-08-16
ATE208205T1 (de) 2001-11-15
CZ300387B6 (cs) 2009-05-06
IL133412A (en) 2003-04-10
MY122501A (en) 2006-04-29
AU8804598A (en) 1999-02-08
BR9810547A (pt) 2000-08-15
EP1003532B2 (en) 2008-11-05
US20020127211A1 (en) 2002-09-12
DE69802413T2 (de) 2002-06-20
EP1003532A1 (en) 2000-05-31

Similar Documents

Publication Publication Date Title
AR013175A1 (es) Uso de bacteria de acido lactico para preparar una composicion oral para mamiferos util para facilitar la absorcion
Senet et al. Hydroxyurea‐induced dermatomyositis‐like eruption
UY34901A (es) ?monohidrato cristalino, procedimiento para su preparacion ysu utilizacion para la preparacion de un medicamento?.
BR9509590A (pt) Aplicação de sod em liposomas
CN108186394A (zh) 一种舒敏修护滋养面膜精华及制备方法
CA2231292A1 (en) Method for decreasing ldl-cholesterol concentration and increasing hdl-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
BR0308799A (pt) co-glóbulos de dha e alecrim e método de uso
ATE225649T1 (de) Arzneizubereitung bestehend aus rhein oder diacerhein mit verbesserter bioverfügbarkeit
KR20220044558A (ko) 칸나비디올을 포함하는 외용 제제, 조성물의 제조 방법 및 이의 용도
HK1055079A1 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
ES2123534T3 (es) Derivados hidrosolubles de la biotina y composiciones terapeuticas relacionadas.
DE69721497D1 (de) Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält
BR0311170A (pt) Método para fornecer uma composição tópica base para uso na preparação de uma composição tópica cosmética, composição cosmética, composição essencialmente anidra, uso da mesma, e, kit de partes para a preparação de uma composição cosmética
AR034920A1 (es) Metodos para el tratamiento de enfermedades intestinales inflamatorias
CN108670902A (zh) 一种除口臭的牙膏
EP0357646A4 (en) Treatment of aged skin with oral 13-cis-retinoic acid
BRPI0417692A (pt) uso de uma composição, método de redução dos efeitos do estresse mediado psicologicamente na pele de um ser humano ou animal, composição, suplemento nutritivo, composição cosmética, e, método para identificar um composto capaz de reduzir os efeitos e método de produção de uma composição para a redução dos efeitos, do estresse mediado psicologicamente sobre a pele de um ser humano ou animal
ITRM910435A1 (it) Preparato farmaceutico da utilizzare quale trattamento coadiuvante della dermatite seborroica anche in soggetti hiv positivi
CN1039087C (zh) 妇科病治疗保健外用药物
WO2007133641A1 (en) Enhanced protection against skin injury in humans
CN108542799A (zh) 一种含维生素c的牙膏
CN108670920A (zh) 一种增白的牙膏
CN101700417B (zh) 人体腔道保健润滑液
CN104432070A (zh) 一种改善皮肤水分的保健食品
Lacour Infectious hypomelanoses

Legal Events

Date Code Title Description
FC Refusal